Investing Ideas
/
Indian Pharmaceuticals & Biotech Potentially Undervalued Companies

Header cover image

Indian Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Apr 21, 2024

Companies with a Value score of at least 3, ordered by Value score

60 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	DRREDDY Dr. Reddy's Laboratories	₹6,016.10	0.09%	25.2%	₹989.6b	₹6,001.87	PE19.2x	E2.5%	0.7%
	532523 Biocon	₹271.00	2.1%	20.2%	₹323.7b	₹278.95	PE27x	E8.7%	0.6%
	532321 Zydus Lifesciences	₹959.45	2.6%	85.5%	₹965.7b	₹838.25	PE32.7x	E8.3%	0.6%
	PPLPHARMA Piramal Pharma	₹141.30	0.9%	97.2%	₹186.9b	₹168.40	PS2.4x	E100.7%	0%
	BIOCON Biocon	₹271.15	2.2%	20.2%	₹312.4b	₹279.11	PE27x	E8.7%	0.6%
	524742 Caplin Point Laboratories	₹1,334.60	2.9%	103.4%	₹99.9b	₹1,579.33	PE23.2x	E1.0%	0.4%
	SUPRIYA Supriya Lifescience	₹390.60	7.4%	73.5%	₹29.3b	₹401.00	PE26.1x	E21.6%	0.2%
	AARTIDRUGS Aarti Drugs	₹493.35	0.6%	17.3%	₹45.6b	₹562.17	PE25.2x	E28.2%	0.2%
	GLS Glenmark Life Sciences	₹839.55	6.1%	80.1%	₹98.3b	₹859.00	PE19.8x	E11.2%	2.7%
	500087 Cipla	₹1,354.25	-2.0%	50.0%	₹1.1t	₹1,451.45	PE29.5x	E11.5%	0.6%
	MARKSANS Marksans Pharma	₹168.05	7.8%	110.6%	₹76.2b	n/a	PE24.1x	E20.6%	0.3%
	524404 Marksans Pharma	₹167.85	7.7%	110.4%	₹76.2b	n/a	PE24.1x	E20.6%	0.3%

Page 3 of 3